Podcasts about Mergers and acquisitions

Plus: IPO documents show Softbank-backed data center venture issued perks to land OpenAI. And SLB acquires data-center cooling company Kelvion for $4.1 billion. Imani Moise hosts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Plus: California publicly traded utilities tumble after state lawmakers reject plan to shield them from wildfire claims. And Aon agrees to a $17 billion deal to buy USI Insurance from KKR. Pierre Bienaimé hosts. Sign up for WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

P.M. Edition for Aug. 14. Money managers have a problem: Clients are holding near-record amounts in cash—by one estimate more than $3 trillion. Miriam Gottfried, a reporter and co-host of WSJ's Take On the Week podcast, explains why this is happening and what financial planners are pushing their clients to do instead. Plus, two pieces of data—July retail sales and the preliminary August reading of the University of Michigan's consumer sentiment survey—came in lower than expected. WSJ economics reporter Matt Grossman says that is painting a picture of a weaker U.S. economy. And AI slop is everywhere, making it hard to know what's real online. We hear from WSJ personal tech columnist Nicole Nguyen about the inspiration for her recent special Tech News Briefing podcast series, “AI and the Blurring of Reality.” Alex Ossola hosts. Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Bloomberg reported that Anthropic is in talks to acquire AI startup Decart for $6 billion. Anthropic, founded in 2021 by Dario and Daniela Amodei, builds the Claude family of models and is backed by large investments from Amazon and Google. A deal of this size would be among the largest in the sector and would likely require a Hart-Scott-Rodino filing and regulatory review. Recent AI transactions include Databricks buying MosaicML for $1.3 billion in 2023, Microsoft's $650 million arrangement with Inflection AI in 2024, and Apple's purchase of DarwinAI in 2024. The potential acquisition would aim to accelerate product delivery, aggregate talent, and strengthen competitive positioning. Founders and enterprise buyers should monitor integration plans, service continuity, and contract terms as consolidation continues.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.

In dieser neuen Folge von CULTiTALK begrüßt Georg die erfahrene Führungskraft Kathrina, Managing Director International und Global Head of Customer Projects bei secunet Security Networks AG. Das Gespräch dreht sich rund um die Herausforderungen und Erfolgsfaktoren von Führung in technologisch geprägten Unternehmen und nimmt dabei insbesondere die Themen Mergers & Acquisitions (M&A), Post-Merge-Integration und den Aufbau einer leistungsfähigen Unternehmenskultur in den Blick. Kathrina schildert ihren Werdegang von der Juristin mit Fokus auf M&A hin zur Führung von internationalen Teams, gibt Einblicke in die Komplexität von Unternehmensübernahmen und wie der echte Integrationsprozess weit über das reine Zusammenführen von Strukturen hinausgeht. Ein zentrales Thema ist dabei für beide: Kultur und psychologische Sicherheit. Sie diskutieren, warum oft der „Best of Both Worlds“-Ansatz in der Integration scheitert, wenn kulturelle Differenzen unterschätzt werden, und weshalb Kommunikation sowie authentische Einbindung der Mitarbeiter erfolgsentscheidend sind. Das Gespräch beleuchtet außerdem Kathrinas gelebtes Führungsverständnis – von ihrer bewussten Entscheidung für den Karriereweg „People Leader“ bis zum Selbstverständnis, als Führungskraft kontinuierlich an sich zu arbeiten und nie auszulernen. Sie verrät, wieso sie sich regelmäßig Coachings sucht, was sie von Leistungssportlern wie Rafael Nadal lernt und warum für sie Klarheit, Echtheit und verantwortungsvolles Erwartungsmanagement im Führungskontext essentiell sind. Zum Abschluss zeigen Georg und Kathrina, dass Leidenschaft für Führung, ein reflektierter Umgang mit unterschiedlichen Persönlichkeiten im Team und psychologische Sicherheit Voraussetzungen für Erfolg und Weiterentwicklung im Unternehmen sind. Wer tiefe Einblicke in modernes Leadership, Teamdynamik und kulturelle Integration sucht, ist in dieser Folge goldrichtig.   Alle Links zu Kathrina Meisl: LinkedIn: https://www.linkedin.com/in/kathrina-meisl/ Unternehmen: https://www.linkedin.com/company/secunet-security-networks-ag/   Alle Links zu Georg und dem Culturizer: Georg: https://www.linkedin.com/in/georg-wolfgang Culturizer: https://culturizer.app CULTiTALK: https://cultitalk.de

What if the biggest threat to your business right now is not moving too slowly? It is moving boldly in the wrong direction. Michael Hofer is a CFO, transformative executive, author, and advisor with 40 years in finance. He has led more than 30 mergers, acquisitions, and restructuring transactions worldwide, giving him a front-row seat to what happens when bold strategy works and when it turns into costly noise. He is the founder of the Thrive Network, where he connects business performance with human potential and health optimization. In this conversation, Larry Olsen sits down with Michael to talk about how leaders can tell whether their next move (AI, M&A, transformation) is creating value or just creating expensive complexity.   ABOUT MICHAEL HOFER Michael Hofer is a CFO, transformative executive, author, and advisor originally from Austria, now based in Denver, Colorado. With 40 years in finance and 30+ mergers, acquisitions, and restructuring transactions worldwide, he brings a rare combination of strategic finance depth and human optimization philosophy. He is currently CFO of a major energy company, MIT-certified in artificial intelligence, and the founder of the Thrive Network. His work spans thriving with diabetes, thriving in business, and thriving in life.   ABOUT LARRY OLSEN Larry Olsen is a Two-Time Vistage Speaker of the Year and Fortune 50/500 Executive Performance Advisor with 40+ years of client work at Toyota, PepsiCo, Starbucks, Harley-Davidson, Honda, American Airlines, State Farm, Frito Lay, Lexus, and Tropicana. He is the author of Get a Vision and Live It! and the founder of Performance Driven Neurology.   IF THIS LANDED FOR YOU The next step is Larry's Brain Hacks Intensive. It is a guided practice that walks you through the foundational mindset shifts Larry teaches Fortune 500 executives. Brain Hacks Intensive: https://neuromindedcollective.com/brain-hacks-challenge   FOR EXECUTIVE LEADERS If you want to find out which patterns are currently running your leadership, take Larry's free 5% Leadership Assessment. Less than 5 percent of leaders operate from the patterns it measures. 5% Leadership Assessment: https://tally.so/r/kde74r   CONNECT WITH LARRY Website: larryolsen.com LinkedIn: linkedin.com/in/larry-r-olsen   CONNECT WITH MICHAEL HOFER Website: bymichaelhofer.com   SUBSCRIBE FOR MORE New episodes of the Brain Vault Podcast publish every other Wednesday.   Yours in growth, Larry  

You may have no plans to sell your agency. But if someone wanted to buy it tomorrow, what would they find? We look at what makes an insurance agency valuable: from clean financials and organized customer data to documented processes, carrier concentration, policies per customer, and an agency that can operate without everything living in the owner's head. When you break down the things a potential buyer would notice, your agency will run more profitability and efficiently.Learn more at IntegraPartnerNetwork.com.

The August edition of the PRmoment podcast's UK pitches, mergers and acquisitions round‑up is steeped in cautious‑no‑more optimism. Host Ben Smith is joined, as ever, by AAR lead consultant and PCB Partners deal‑maker Andrew Bloch, who declares that the market mood has decisively shifted. Don't forget to get your tickets for the Creative Moment Awards, coming up in September.Bloch reports that the usual summer slowdown never arrived. Instead, he describes “the busiest summer I've ever, ever seen, despite everyone being on holiday” [0:02:01], with frenetic activity on both the pitch and M&A fronts. September, he predicts, “is going to go nuts” as agencies head into a packed autumn new‑business season.Here are some highlights from this week's show:[0:01:27] Andrew Bloch: “I'm going to drop the cautious today. I think everyone is feeling pretty buoyant and optimistic… the last couple of months have been a much‑needed shot in the arm for a lot of firms heading into the second half of the year.” [0:02:01] Andrew Bloch: “There's just a feeling of, we've just got to get on with stuff… the summer's busy. It's the busiest summer I've ever, ever seen, despite everyone being on holiday!”[0:03:38] Andrew Bloch: “The smartest firms on the market are moving quick to buy in AI capabilities, rather than building it at a slower pace.”[0:03:38] Andrew Bloch: “We're seeing global network expansion firmly back on the agenda – a lot of American firms using bolt‑on acquisitions to stake out positions in markets they can't afford to ignore.”[0:05:38] Andrew Bloch: “Hugo Boss has appointed M&C Saatchi Sport & Entertainment on more or less a global brief… it really touches on their sweet spot of understanding culture, sport and entertainment.”[0:09:10] Andrew Bloch: “Sky Sports have added Spike to their roster to create culturally driven activations designed to connect with sports fans beyond live broadcasts.”[0:13:59] Andrew Bloch: “I'm of the firm belief that when done well, PR is the best discipline to run influencer campaigns because they understand storytelling.”[0:19:02] Andrew Bloch: “The National Lottery Community Fund's £3 million AI fund is designed to make sure marginalised groups aren't left behind by rapid advances in technology.”[0:20:14] Andrew Bloch: “The travel industry is grappling hard and fast to work out how to capitalise on changes in search and protect themselves from declines in traditional SEO.”[0:30:41] Andrew Bloch: “AI is an integral part of how any modern comms firm has to create value for clients… it's not a conversation that's ever going to go away.”On the deals side, three structural themes dominate. First, EOTs continue to entrench themselves as a mainstream exit route for founders. Eulogy and Field Consulting are the latest to go down the employee‑ownership path, joining a growing list that includes Citypress, Brands2Life and W. The tax regime has tightened but remains attractive. “The current capital gains tax on an EOT is 12%… they remain a very viable option, with lots of pros – not to say there aren't cons as well”  [0:26:17].Second, AI has moved firmly from buzzword to board‑level requirement. “The smartest firms on the market are moving quick to buy in AI capabilities, rather than building it at a slower pace” [0:03:38], says Bloch.Parity's acquisition of AI advisory firm Enigma is the standout example, aimed at helping clients become “AI‑native” and future‑proofing the group's own proposition. More broadly, he argues, “AI is an integral part of how any modern comms firm has to create value for clients… it's not a conversation that's ever going to go away” [0:30:41].Third, global network expansion is back in fashion, particularly for US‑headquartered groups. “We're seeing global network expansion firmly back on the agenda – a lot of American firms using bolt‑on acquisitions to stake out positions in markets they can't afford to ignore” [0:03:38]. Finn Partners' buy of Australian corporate shop Honner and FGS's Washington DC acquisition of Rich Foley & Anderson are cast as emblematic of this land‑grab in financial and public affairs work.On the pitch front, the episode reads like a roll‑call of heavyweight consumer and corporate briefs. Hugo Boss hands a multi‑market mandate to M&C Saatchi Sport & Entertainment, a win Bloch says “really touches on their sweet spot of understanding culture, sport and entertainment” [0:05:38]. Adobe's UK and EMEA comms move to Burson in what Bloch calls “a whopper of a win” [0:07:47], stretching across corporate reputation, AI storytelling, creator comms and hub‑agency coordination.Influencer and social briefs are another clear through‑line. Mischief's Matalan win underlines Bloch's conviction that, “when done well, PR is the best discipline to run influencer campaigns because they understand storytelling” [0:13:59].Uncovered's social mandate for Weetabix and Alpen, and Milk & Honey's work on the National Lottery Community Fund's £3m AI fund – “designed to make sure marginalised groups aren't left behind by rapid advances in technology” [0:19:02] – round out a month that suggests UK PR is not just busy, but structurally evolving around AI, ownership models and genuinely integrated campaigning.

Plus: Boeing is selling its flying-taxi venture to Archer Aviation. And the Iran war has been a boon for Chinese EV companies. Danny Lewis hosts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Owner dependency is the quiet risk that caps valuations in IT services M&A. If every decision, client relationship, and process runs through the founder, buyers see a single point of failure and pay less for it. In this episode of Shoot the Moon, we break down how to get the business out of your head before you sell. We cover why buyers discount founder-run companies, what to document first, how AI has made process documentation far easier, and how a documented, transferable business can earn a higher multiple. This is core IT services M&A preparation, and it makes your company more valuable whether or not you ever go to market. CHAPTERS 0:00 Intro: Getting the business out of your head0:53 A job with employees, not a company2:36 Why buyers discount owner dependency6:29 Why IT services founders get stuck11:41 What to document first16:36 AI, repeatability, and productized services20:43 How documentation lifts enterprise value24:08 Building a culture of documentation27:45 The one thing to start this month KEY TAKEAWAYS • Owner dependency is concentration risk. When decisions bottleneck through the founder, buyers see a single point of failure and discount the price. • If the answer to everything is “ask the owner,” you own a job not a company. Continuity is what buyers pay for. • Start documenting where the customer sits: the sales motion first, then service delivery, followed by how you hire and develop people. Bring the team into the process. • AI has collapsed the cost of documentation. Capture the real process, optimize it, and build agents around it. • Documented, transferable businesses can earn higher multiples because buyers underwriting scale need a company they can integrate without depending on the founder. RESOURCES AND LINKS • Read more from Revenue Rocket: https://www.revenuerocket.com/blog/ • Value your business: https://www.revenuerocket.com/valuation-calculator/ • Schedule a confidential conversation: https://www.revenuerocket.com/contact-us/ • Listen on Apple Podcasts: https://podcasts.apple.com/us/podcast/shoot-the-moon-with-revenue-rocket/id1478519505 • Listen on Spotify: https://open.spotify.com/show/6y7u9KuOjaplhScHtINGZU • Explore more Shoot the Moon episodes: https://www.revenuerocket.com/series/shoot-the-moon/ • Visit Revenue Rocket: https://www.revenuerocket.com/ ABOUT REVENUE ROCKET Revenue Rocket is a sell-side and buy side M&A advisory firm focused exclusively on IT services companies, including MSPs, cybersecurity firms, cloud service providers, custom application development companies, and VARs. For more than 25 years, Revenue Rocket has helped founders grow, position, buy, and sell tech-enabled services firms. Thinking about your own exit? Schedule a confidential conversation with our team:https://www.revenuerocket.com/contact-us/ #MergersAndAcquisitions #ITServices #MSP #ShootTheMoon #RevenueRocket #ExitStrategy #FounderDependency #EnterpriseValue Listen to Shoot the Moon on Apple Podcasts or Spotify.Buy, sell, or grow your tech-enabled services firm with Revenue Rocket.

In IT services M&A, owner dependency is one of the biggest hidden discounts on your company's value. This episode shows how to build an owner optional firm that buyers pay a premium for without pretending leadership does not matter. Revenue Rocket kicks off a new Shoot the Moon masterclass on reducing founder dependency before a sale or recapitalization. We break down why buyers price owner dependency as concentration risk, what an owner-optional firm actually looks like, and the leadership layer, sales transfer, and key-employee retention strategies that protect your multiple. If you are thinking about an exit, this is the IT services M&A preparation that pays off long before you go to market. CHAPTERS 0:00 Introduction: The owner-optional firm3:44 What owner dependency costs you at exit5:26 Replaceable, not optional10:06 The one-percenter salesperson problem13:40 The minimum leadership layer buyers expect18:29 Keeping your key people through a sale21:11 One move to make this quarter25:30 What is next in this masterclass series IN THIS EPISODE • Buyers price owner dependency as concentration risk, much like they treat a client representing 50% to 70% of revenue. • Owner-optional does not mean owner absent. No CEO is optional; the goal is to make critical roles replaceable. • The founder's sales role is usually the highest-value dependency to transfer first. • Buyers expect a real leadership layer, including finance, delivery, and technical depth beyond the founder. • Plan key-employee retention before the deal not during it. RESOURCES AND LINKS • Read more from Revenue Rocket: https://www.revenuerocket.com/blog/ • What is your firm worth? https://www.revenuerocket.com/valuation-calculator/ • Schedule a confidential conversation: https://www.revenuerocket.com/contact-us/ • Listen on Apple Podcasts: https://podcasts.apple.com/us/podcast/shoot-the-moon-with-revenue-rocket/id1478519505 • Listen on Spotify: https://open.spotify.com/show/6y7u9KuOjaplhScHtINGZU • Explore more Shoot the Moon episodes: https://www.revenuerocket.com/series/shoot-the-moon/ • Learn more about Revenue Rocket: https://www.revenuerocket.com/ ABOUT REVENUE ROCKET Revenue Rocket is a sell-side and buy-side M&A advisory firm focused exclusively on IT services companies, including MSPs, cybersecurity firms, cloud service providers, custom application development companies, and VARs. For more than 25 years, Revenue Rocket has helped founders grow, position, buy, and sell tech-enabled services firms. Thinking about your own exit? Schedule a confidential conversation with our team:https://www.revenuerocket.com/contact-us/ #MergersAndAcquisitions #ITServices #MSP #ShootTheMoon #RevenueRocket #ExitStrategy #OwnerOptional #FounderDependency Listen to Shoot the Moon on Apple Podcasts or Spotify.Buy, sell, or grow your tech-enabled services firm with Revenue Rocket.

Plus: SpaceX releases first-ever quarterly financial report. And Palantir shares surge after the software company reported stronger-than-expected earnings. Imani Moise hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Plus: AstraZeneca and Bristol Myers Squibb shares swing on reports of a potential tie up. And Nissan reports its first quarterly profit in two years. Imani Moise hosts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Revenue Rocket's Mike Harvath, Ryan Barnett, and Matt Lockhart break down the real reasons founders delay an exit, and why the safest-feeling choice is often the most expensive. This episode of Shoot the Moon covers the “one more year” trap, founder dependency, succession planning, derisking customer concentration and contracts, and why knowing your valuation is the first move in IT services M&A. If you run an MSP, MSSP, cloud, dev, or VAR business, this is the timing conversation to have before the market decides for you. CHAPTERS 0:00 Cold open and welcome 1:56 Why founders delay a sale (the “one more year” trap) 5:46 Run it forever, but stay ready to sell 6:26 Owner dependency and building a machine 12:27 What succession planning really looks like 16:07 Enjoy what you have built vs. the window to sell 21:30 De-risking: customer concentration and contracts 22:23 Know your number: the case for annual valuations 24:40 One move to make this week 28:45 Closing thoughts: have a plan KEY TAKEAWAYS ● Waiting one more year can lower value, not just raise it. You carry 100% of the downside. ● Buyers pay for a business that runs without you. Build the bench and reduce founder dependency. ● Real succession planning is documented and executable, not a someday idea. ● De-risk before you go to market: diversify clients, fix contract assignability, deepen the team. ● Know your number. An annual valuation is good corporate hygiene and a stage gate for timing. LINKS ● Blog post: [BLOG LINK] ● Valuation calculator: revenuerocket.com/valuation-calculator ● Schedule a confidential conversation: [SCHEDULING LINK] ● Website: revenuerocket.com ABOUT REVENUE ROCKET Revenue Rocket is a sell-side and buy-side M&A advisory firm focused exclusively on IT services companies, including MSPs, cybersecurity, cloud, custom application development, and VARs. HASHTAGS #MergersAndAcquisitions #ITServices #MSP #ShootTheMoon #RevenueRocket #ExitStrategy #SuccessionPlanning #BusinessValuation Thinking about your own timing? Schedule a confidential conversation with Revenue Rocket at revenuerocket.com/contact-us. Listen to Shoot the Moon on Apple Podcasts or Spotify.Buy, sell, or grow your tech-enabled services firm with Revenue Rocket.

Plus, Boeing logs another quarterly loss amid spending push on new Air Force One jets. And, PayPal's CEO says he's open to evaluating sale offers, while focusing on the company's turnaround plan. Alex Ossola hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Plus: OpenAI says two of its models hacked a company in a cybersecurity test gone wrong. And U.S. data-center operator TECfusions plans to go public. Danny Lewis hosts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Plus: Carl Icahn's company agrees to sell auto-service chain Pep Boys. And Ukraine strikes a deal with defense company BAE Systems to manufacture howitzers locally. Alex Ossola hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Plus: Oil tops $90 a barrel as Middle East conflict continues. And shares of Utz Brands soar after the snack-food maker agrees to go private. Imani Moise hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Joe Davi, Chief Executive Officer, Med-Metrix, discusses how healthcare organizations can strengthen revenue cycle integration to capture the full value of mergers and acquisitions. He shares strategies for successful post-merger execution, standardizing operations, and leveraging AI to improve efficiency, productivity, and long-term financial performance.This episode is sponsored by Med Metrix.

Stewart Alsop sits down with investor and entrepreneur Adnan Hassan on the Crazy Wisdom Podcast to explore his thesis on creating a small state asset class, using evolutionary insights from asteroids, dinosaurs, and mycelium as a framework for understanding resilient systems. Hassan brings his background in Silicon Valley technology, New York and Washington finance, and sovereign funds—including senior leadership roles at the World Bank—to explain why 162 of the world's 200 states are actually small states with populations under 12 million, and why these distributed, autonomous entities might be best positioned to survive the coming global shocks from AI, currency disruption, and the wobbling international order. For more information about Hassan's work, visit www.sac-holding.com (SAC stands for Small State Asset Class), where you can find two-minute videos explaining his approach to building this new financial architecture.Timestamps00:00 Introduction and the asteroid, dinosaur, mycelium thesis as a framework for understanding evolutionary survival patterns across billions of years05:00 Global order institutions are wobbling while currency systems evolve and AI emerges, creating simultaneous shocks that favor adaptable networked systems over large centralized structures10:00 Small states defined as populations under 12 million represent 162 of 200 global economies, contradicting assumptions that most nations are large centralized powers15:00 States behave as selfish entities seeking regulatory control while individuals seek autonomy, creating tension as the Westphalian system undergoes fundamental transformation20:00 Cooperation versus competition in human systems, examining how KYC requirements and state surveillance are expanding globally including in America and Argentina25:00 Small states are most interested in rule-based global order because they need protection from larger powers, unlike powerful nations that prefer unconstrained action30:00 Of the twenty richest countries by per capita GDP, seventeen are small states, yet no small state asset class exists in financial markets35:00 Uncorrelated assets provide diversification protection for investors, while small states offer geographic distribution across Caribbean, Africa, Europe, Gulf, and Pacific regions40:00 Cross-border family business collaboration between small states will increase, leading to knowledge sharing and a proposed Davos for small states event45:00 The individual sits at the core of this framework, with AI enabling creative minds in small places to access world-class resources previously impossible50:00 Demonstration of accessible technology costing only ten dollars shows how AI removes barriers, allowing creativity to become the distinguishing factor for entrepreneurs globallyKey Insights1. Adnan Hassan presents a thesis grounded in billions of years of evolutionary data, arguing that systems which survive major shocks share common characteristics: they are autonomous, networked, cooperative, resilient, and lack single points of failure. He uses the asteroid strike that killed the dinosaurs as his central metaphor, noting that while massive dinosaurs went extinct, smaller organisms like mycelium, ants, bees, and marsupials survived because of their distributed and adaptable nature. Hassan believes we are currently experiencing a similar asteroid-level shock to our global systems through the simultaneous disruption of the rule-based global order, currency systems, and artificial intelligence, all happening at once over the next three to five years.2. Hassan identifies 162 out of 200 global states and economies as small states, defined as having populations under 12 million people. This number surprises most people, including sophisticated observers who typically guess around 60 or 70. Even more striking, 17 of the 20 richest countries by per capita GDP are small states, representing 85 percent of the wealthiest nations. These small states have disproportionate resources to deploy internationally and the greatest interest in maintaining a rule-based global order since they have the most to lose from chaos and cannot rely on size or military power for protection.3. The current global institutional framework established after World War Two, including the UN, IMF, World Bank, and WTO, is fundamentally wobbling and reaching the end of an era. Hassan argues that states are inherently selfish creatures addicted to regulatory sovereignty and control, but the systems designed to give these states structure and credibility are now failing. This represents the first major restructuring of the global order since the post-World War Two period, which itself followed 400 years of colonial systems. The transition period will be characterized by significant chaos and convulsions throughout the global system.4. Hassan advocates for creating a new small states asset class in financial markets, which does not currently exist despite small states representing the majority of countries and the wealthiest per capita economies. This asset class would provide large institutional investors like pension funds and sovereign wealth funds with globally diversified, potentially uncorrelated assets while simultaneously supporting political and economic structures that embody the evolutionary principles of survival through distributed, autonomous, networked cooperation. The small states asset class represents both sound evolutionary strategy and pragmatic investment opportunity.5. Technology without philosophy is efficiency without purpose, a concern Hassan raised as early as 1994 when he helped prototype the first electronic trading market on the internet. He witnessed the naive optimism of Silicon Valley technologists who believed simply throwing tools over the wall would create a better world, but this approach made both good and bad activities more efficient. Social media demonstrated this danger by efficiently creating disruption and loss of trust in political systems. Hassan warns that the same mistake is being made with AI, where powerful tools are being deployed without adequate philosophical framework or consideration of consequences.6. Small states and their leading families will find more common language and shared understanding with each other across geographic boundaries than with larger neighboring states. A family business in Montevideo has an easier conversation with counterparts in Singapore or New Zealand than with businesses in Sao Paulo because small state actors recognize each other's unique realities and circumstances. Hassan plans to create a Davos for small states in 2027 to facilitate this knowledge sharing among the mycelium colony, allowing different nodes to exchange innovations and strategies across the distributed global network of small state actors.7. The optimistic future involves unleashing individual creativity globally by giving people access to AI-enabled tools that provide world-class legal, financial, and consulting advice in their language of choice. The solopreneur can now become a conglomerate, with individuals no longer constrained by lack of access to execution machinery. Hassan envisions young people in places like Gabon, Swaziland, or Uruguay having the same access to sophisticated business infrastructure as those in traditional power centers, with the distinguishing factor being creativity of mind rather than geographic or institutional privilege. Small states can pivot faster on regulatory frameworks, sometimes achieving in a dinner meeting what takes large states three years of legislative, executive, and judicial wrangling.

06-25-2026 Gene Townley Learn more about the interview and get additional links here: https://thedailyblaze.com/look-at-your-books-like-a-mergers-and-acquisitions-expert/ Subscribe to the best of our content here: https://priceofbusiness.substack.com/ Subscribe to our YouTube channel here: https://www.youtube.com/channel/UCywgbHv7dpiBG2Qswr_ceEQ

Most businesses will go through some kind of change management challenge – a new tool, a restructure, a rebrand. But what does it look like when you're doing that across eight acquired businesses, each with their own people, systems, culture, and way of doing things?Jonathan Healey is Group Technology Director at IDHL, a 500-person UK digital agency group that has grown through eight acquisitions. He's been at the center of every integration – aligning systems, consolidating brands, and figuring out what actually has to happen, and in what order, before any of it can work.This is a conversation about what M&A integration really looks like on the ground – and why, at its core, it's a change management problem more than a technology one.Here's what we get into:• Why the back office has to move first – and what happens when it doesn't• The "us vs them" dynamic that can derail an integration before it starts• How to decide what to standardize and what to leave alone• Why process is poison – and what good process actually looks like• Build vs buy: when in-house systems become a liability• AI adoption as a change management challenge – and the federated model IDHL is using to scale itWhether you're navigating an acquisition, thinking about one, or just trying to get a new way of working to stick across your team – this one's got something for you.Additional Resources:

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The pharmaceutical and biotech industries are undergoing significant transformations, driven by scientific advancements, regulatory changes, and strategic investments. These developments are shaping the landscape of drug development and patient care in profound ways. In recent news, Pfizer's CEO, Albert Bourla, is reconsidering investments in Germany due to proposed healthcare reforms. These reforms have sparked concerns about their potential impact on the pharmaceutical industry. This situation highlights the intricate balance between regulatory frameworks and corporate strategies, illustrating how policy changes can influence investment decisions and operational strategies within the pharma sector. The tension between regulatory environments and corporate interests is a recurring theme that continues to shape strategic directions within the industry. Meanwhile, heightened scrutiny over biotechnology operations is evident with Wuxi AppTec's inclusion on the Pentagon's blacklist under the Biosecure Act. This move reflects growing concerns about biosecurity and the necessity for stringent oversight in handling sensitive biotechnological advancements. Such actions underscore a global focus on safeguarding national security while fostering scientific innovation. Teva Pharmaceuticals is navigating restructuring efforts by laying off 250 employees at its Active Pharmaceutical Ingredients unit as it seeks a new owner. This restructuring underscores the challenges companies face in maintaining operational efficiency amid ownership transitions. These challenges are emblematic of broader industry dynamics where companies strive to adapt to changing market conditions while ensuring stability and growth. On the scientific front, Novo Nordisk's cagrisema and Eli Lilly's retatrutide are emerging as next-generation incretin therapies. Although early comparisons have been made, Novo Nordisk's chief scientific officer suggests it is premature to declare a definitive leader. This competition reflects the dynamic nature of drug development as companies strive to innovate and improve treatment options continuously. Additionally, Sonothera's successful $125 million Series B funding round for its bubble-based genetic delivery system highlights the biotech industry's momentum fueled by mergers and acquisitions (M&A) and partnerships. Such technologies promise to advance genetic therapies by enhancing delivery mechanisms, potentially transforming treatment paradigms for various genetic disorders. AbbVie's Skyrizi narrowly surpassing Johnson & Johnson's Tremfya in May drug ad spending underscores the competitive nature of pharmaceutical marketing. Despite a general slump in advertising expenditures among leading drugs, strategic marketing remains crucial for maintaining brand presence and market share. Increased M&A activity and partnerships are further bolstering the industry's growth trajectory. The resurgence of Initial Public Offerings (IPOs) and venture capital funding is fostering innovation and expansion within the sector, providing fuel for continued advancement in biotech. On the regulatory front, Johnson & Johnson's Darzalex received a new endorsement from NICE after a prior reversal. Such regulatory updates emphasize the evolving nature of drug approvals and market access strategies essential for pharmaceutical companies' success. Novartis' second deal with Orionis Biosciences worth up to $1.4 billion exemplifies strategic investments aimed at expanding research capabilities and addressing unmet medical needs through molecular glue technologies targeting challenging therapeutic areas. Conversely, Sanofi's decision to halt a Phase 3 autoimmune trial due to insufficient efficacy highlights the inherent risks in drug development pipelines. These setbacks emphasize the importance of robust clinical trial designs and adaptability in R&D strategies. Emerging insights into GLP-1 drugs like Novo Nordisk's semaglutide reveal potential antidepressant effects linked to gut microbiota modulation. These findings open new avenues for exploring psychiatric applications of metabolic drugs, although conflicting data necessitates further investigation. Overall, these developments illustrate a complex interplay of scientific innovation, regulatory dynamics, and strategic corporate actions driving the future of pharmaceuticals and biotechnology. The sector continues to navigate challenges while capitalizing on opportunities to enhance patient care through advanced therapeutic solutions. The industry's trajectory promises transformative impacts on patient care through novel therapies designed not only to treat symptoms but also address root causes via innovative science-driven solutions. As these advancements unfold, they herald a new era of targeted, effective treatments that hold promise for improving patient outcomes across diverse medical landscapes.Support the show

Send us Fan MailIn this powerful investor panel clip, a serial entrepreneur with exits to Apple, Oracle, and SAP shares what founders get wrong about building companies for acquisition.After multiple successful exits and a decade at Apple, he explains why chasing a sale too early destroys priorities — and why the best acquisitions happen when you build a real solution first.He also discusses the future of Applied AI, how AI will organize our chaotic digital lives, and why adversity often creates the biggest breakthroughs.Topics Covered:✅ Founder with exits to Apple, Oracle & SAP shares lessons✅ Why building to sell is usually the wrong strategy✅ Jeff Bezos “missionaries vs mercenaries” mindset✅ How great acquisitions actually happen✅ Applied AI opportunities in daily life✅ Why adversity often leads to success✅ Building startups the right way in 2026If you're a founder, investor, entrepreneur, or startup operator, this is a must-watch.

Today's episode includes a discussion on the various mergers and acquisitions we are seeing around the mortgage and real estate industries. Plus, Robbie sits down for an interview with TD Bank's Scott Lindner on the shift in how first-time buyers are approaching homeownership, as affordability challenges continue to reshape expectations, timelines and financial preparation. The episode closes with a look ahead to how Federal Reserve Chair Warsh may reshape the central bank in his image.Thank you to Experian Verify, a comprehensive income and employment verification solution for mortgage lenders. By uniting instant payroll data, permissioned access, and research verification in one seamless experience, Experian Verify helps lenders reduce friction, accelerate decisions, and confidently verify every U.S. worker.The Chrisman Commentary is your go-to daily mortgage news podcast, where industry insights meet expert analysis. Hosted by Robbie Chrisman, this podcast delivers the latest updates on mortgage rates, capital markets, and the forces shaping the housing finance landscape. Whether you're a seasoned professional or just looking to stay informed, you'll get clear, concise breakdowns of market trends and economic shifts that impact the mortgage world.

Most people don't fear change itself — they fear the moment before they know if they're going to be okay. And according to Dr. Jimmie Williamson, that gap between uncertainty and clarity is where organizations either hold their people together or quietly lose them. In this episode of Your Health University, Jamie sits down with Dr. Jimmie Williamson, Chief Behavioral Health Officer at Your Health, in the middle of a real organizational merger — making this conversation as timely and personal as it gets. Dr. Williamson draws on decades of clinical experience, behavioral health expertise, and his own career pivots (including leaving a 28-year career to step into healthcare) to walk us through what change actually does to the human brain and body — and what it takes to move through it well. Key topics include: Why even positive change triggers a physiological threat response — and what science says is actually happening in your brain The five stages of change people move through (shock, resistance, exploration, and beyond) and why getting stuck isn't a character flaw Dr. David Rock's SCARF model — the five psychological domains (Status, Certainty, Autonomy, Relatedness, Fairness) that determine whether people feel safe or threatened during transitions What leaders most commonly get wrong when communicating change — and the one mistake that always creates a narrative vacuum Why insecurity in leadership is more dangerous than the change itself The one self-care practice you can start today if you're feeling the weight of uncertainty Change is positive. It is good. And it is inevitable. This episode will help you believe that — and act like it. www.YourHealth.Org

AB sits down with Ammar Maraqa, Cisco's Chief Strategy Officer, to discuss topics such as turning an acquisition into a competitive advantage, fostering an agile and customer-centric culture, aligning business cases with long-term innovation goals to drive real value, and much more.

Hi, welcome back to ValuationPodcast.com — a podcast and video series about all things related to business and valuation. I'm Melissa Gragg, a financial mediator and business valuation expert in St. Louis, Missouri.When it comes to buying or selling a business, most people focus on one thing—the price. But what if I told you that the price is only the beginning, and that millions can be won or lost in the details of the deal itself?In today's episode, I'm joined by Holli Moeini, a seasoned CFO, CPA, and M&A advisor who has seen firsthand how deals can quietly erode—or significantly increase—value depending on how they're structured. As someone who works closely with business owners navigating valuation, mediation, and complex financial decisions, I've also witnessed how easy it is to overlook critical elements that ultimately shape the outcome of a transaction.Together, we dive into the hidden layers of mergers and acquisitions—where working capital, earnouts, due diligence, and financial storytelling can make or break a deal. Holli shares insights from her book Finding the Missing Millions in M&A and breaks down where business owners unknowingly leave money on the table.If you're a business owner, investor, or advisor, this conversation will challenge the way you think about value—and show you why preparation, strategy, and the right guidance matter far more than you might expect.Key Takeaways:Price is Only One Piece of the Puzzle The final deal value is heavily influenced by structure, terms, and execution—not just the headline number.Preparation Drives Value Businesses that are financially organized, operationally structured, and strategically positioned command higher multiples.Working Capital Can Make or Break Deals Misunderstanding working capital expectations can swing deals by hundreds of thousands—or even millions.Earnouts Require Precision Without clear definitions, control, and measurement cadence, earnouts can lead to significant financial loss and disputes.Financial Storytelling Builds Trust (and Price) Buyers assess not just numbers, but credibility. Inconsistent or unclear financial narratives reduce perceived value.Q&As from episode:Q1: What is the biggest mistake business owners make when selling their company? A: The biggest mistake is focusing only on the sale price while ignoring deal structure elements like working capital, earnouts, and financial presentation, which can significantly impact final value.Q2: How can a business owner increase the value of their company before selling? A: By cleaning up financial records, preparing accrual-based statements, building a strong leadership team, and creating clear, consistent financial narratives that reduce buyer risk.Q3: What is working capital in an M&A deal and why does it matter? A: Working capital represents the short-term assets needed to run the business post-sale. Mismanaging it can reduce the seller's proceeds or even jeopardize the deal.Q4: What is an earnout and how can it affect the sale price? A: An earnout is a performance-based payment after the sale. If poorly structured, it can result in sellers not receiving expected payouts due to unclear terms or lack of control.Q5: Why is due diligence so important in mergers and acquisitions? A: Due diligence uncovers financial, legal, and operational risks. Poor preparation can lead to deal renegotiation, reduced valuation, or complete deal failure.Holli Moeinihttps://hollimoeini.com/https://www.linkedin.com/in/hollimoeini/ holli@hollimoeini.com Melissa Gragghttps://www.valuationmediation.com/https://www.youtube.com/@BusinessValuationStLSupport the show

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into the dynamic shifts and breakthroughs shaping this ever-evolving industry. In a significant regulatory update, the resignation of FDA Commissioner Marty Makary has stirred discussions across the pharmaceutical landscape. Over his 13-month tenure, Makary faced considerable scrutiny for his controversial decisions, including the rejection of several rare disease drugs. This leadership change at the FDA may herald a period of uncertainty as the agency searches for new direction amidst criticisms and operational challenges. The implications are vast, potentially affecting drug approval processes and public health policies, making it crucial for stakeholders to watch closely how the agency adapts to this transition. Simultaneously, Takeda's announcement to lay off 4,500 employees marks a strategic move to streamline operations and focus on core competencies. This decision reflects a broader industry trend where companies are optimizing their structures to enhance financial health in a highly competitive market. The cost savings from this restructuring are expected to be substantial, allowing Takeda to pivot towards more sustainable business models and focus on areas that promise future growth. Eli Lilly and Novo Nordisk continue to lead in drug development with their GLP-1 receptor agonists. Both companies have reported promising data on early response and long-term weight loss maintenance in patients, positioning their therapies as pivotal in treating obesity. Eli Lilly's obesity treatments Foundayo (orforglipron) and Zepbound (tirzepatide) have shown sustained weight-loss maintenance in Phase 3 trials, reinforcing their efficacy in metabolic health interventions. These developments not only highlight the intense competition in the GLP-1 space but also underscore the potential impact on addressing global obesity challenges effectively. The strategic landscape of mergers and acquisitions is also evolving with Merck KGaA's announcement to bolster its pipeline through strategic M&A activities. This move is emblematic of an industry-wide strategy where companies seek external innovation to fill pipeline gaps, ensuring sustained growth and competitiveness. In a related vein, BioMarin's $4.8 billion acquisition of Amicus Therapeutics signifies a firm commitment to addressing unmet needs in rare diseases, illustrating how consolidation can enhance capabilities in niche markets with significant potential. In vaccine development, Valneva's decision to reduce its workforce by up to 15% highlights ongoing challenges in the sector, particularly for travel-related vaccines affected by global market trends. This restructuring is indicative of the volatility faced by companies as they adapt strategies for long-term sustainability amidst shifting consumer behaviors. Pfizer's expansion into Europe with its hemophilia treatment Hympavzi marks a critical regulatory milestone, broadening its market presence and offering expanded therapeutic options for patients. This approval not only strengthens Pfizer's foothold in the hemophilia market but also exemplifies the global reach of innovative treatments. Technological integration continues to revolutionize R&D processes, as evidenced by AstraZeneca's licensing agreement with Owkin for AI capabilities. This partnership aims to harness AI-driven insights for drug discovery, showcasing how technology is reshaping traditional research methodologies and enhancing efficiency. Similarly, advancements in AI-powered diagnostics are evidenced by Boehringer Ingelheim's collaboration with Brainomix in pulmonary fibrosis imaging, reflecting broader trends towards personalized medicine through precise disease characterization. Kyverna Therapeutics is advancing in cell therapy with Support the show

As many life sciences companies prepare for strategic exits, existing collaboration partners can make or break the deal. Join Troutman Pepper Locke Partners Mindy Rudolph and Mandy Hassan as they discuss how targets can navigate M&A transactions when key assets are tied up in complex licensing and collaboration arrangements. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

(0:00) Intro (1:36) About the podcast sponsor: The American College of Governance Counsel (2:23) Start of interview (3:11) Steve's origin story (5:05) His Journey into Journalism (6:02) The Rise of Governance Movement (7:00) Transformation of Board Accountability. Reference to the 1992 Board coup at GM and other historical changes. (10:24) Communication in Governance (12:25) Establishing Gladstone Place Partners (15:00) Crisis Management and Board Roles (17:34) The Importance of Investor Relations (20:40) Current Landscape of Shareholder Activism.  (25:14) The Snap activism case. The impact of activism on companies with dual-class share structures. (30:12) M&A Transactions, Delaware and DExit. The impact of Twitter's acquisition by Elon Musk. Reference to E201 with Leo Strine. (34:47) The Ongoing Cybersecurity Challenge. Reference to Anthropic's new Claude Mythos.  (37:51) The Impact of AI on Governance. The case of Anthropic's dispute with the Pentagon. *Reference to evanepstein.substack.com and E204 with Eric Ries. (42:50) AI's PR problem. The challenge of building data centers. The geopolitics of AI. (46:30) Impact of job firings, due to AI? (49:53) The state of ESG and DEI in 2026. (52:05) Books that have greatly influenced his life: The Island at the Center of the World, by Russell Shorto (2004) The Power Broker, by Robert Caro (1974) Alexander Hamilton, by Ron Chernow (2004) (53:10) His mentors.  (54:00) Quotes that he thinks of often or lives her life by (Grateful Dead lyrics) (54:24) An unusual habit or an absurd thing that he loves (55:06) The living person he most admires Steven Lipin is founder and CEO of communications advisory firm Gladstone Place Partners and a trusted advisor in the field of strategic, financial and corporate governance communications. You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License

David Clark is a partner at Olivewood Advisors. 

In this episode of Zero to CEO, Capital Futurist Reagan Rodriguez pulls back the curtain on the world of private capital networks and reveals how high-trust dealmakers acquire and scale businesses off the radar. As founder of the 5th Avenue Underground Club, Reagan shares how zero-down acquisitions work, why traditional funding often fails entrepreneurs, and how to tap into the hidden economy of private deal flow. If you're looking for alternative ways to fund and grow your business, this episode is your inside pass.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of transformative events shaping the industry, from groundbreaking drug approvals to strategic corporate maneuvers.Recently, the U.S. Food and Drug Administration (FDA) granted approval for Eli Lilly's new GLP-1 receptor agonist pill, Foundayoby, marking a significant milestone as it's the first new molecular entity to be cleared under the FDA's Commissioners National Priority Voucher Program. This program is designed to expedite the review process for drugs addressing critical needs or representing substantial advancements in treatment. Foundayoby's entry into the market provides a competitive edge against Novo Nordisk's products, offering a convenient oral alternative in the management of type 2 diabetes and obesity. Clinical trials have shown that this oral formulation maintains efficacy comparable to injectable peptides while improving patient adherence due to its ease of use. This development not only broadens therapeutic options but also emphasizes the growing trend towards patient-centric formulations in diabetes management.In related news, Eli Lilly has also received FDA approval for its oral obesity medication, Orforglipron, marketed as Foundayo. This approval further intensifies the rivalry with Novo Nordisk, which launched its oral therapy Wegovy earlier. Orforglipron's clinical trials demonstrated significant weight reduction in patients, highlighting pharmacotherapy's rising importance as an option for individuals struggling with obesity despite lifestyle modifications. The convenience of an oral formulation is expected to enhance patient compliance and long-term success, addressing a key challenge in obesity management.In strategic corporate news, Korsana Biosciences is making waves by entering public markets through a reverse merger with Cyclerion. This move highlights ongoing interest and investment in neurodegenerative diseases like Alzheimer's. In contrast, KBP Biosciences faces legal challenges as it seeks to reclaim ownership of heart drug Ocedurenone from Novo Nordisk after a failed billion-dollar deal. Such cases underscore the complexities inherent in pharmaceutical collaborations.Regulatory scrutiny continues to play a crucial role in shaping industry dynamics. The FDA extended its review period for Orca Bio's novel cell therapy for blood cancers by three months. This delay reflects rigorous regulatory requirements for innovative treatments poised to transform oncology care paradigms. Meanwhile, Iterum Therapeutics is winding down operations following unsuccessful sales of its antibiotic Orlynvah, highlighting financial sustainability challenges within the antibiotic market.Safety remains paramount as evidenced by concerns over Amgen's Tavneos after reports of serious liver injuries linked to its use. The FDA has identified 76 cases, including fatalities, underscoring the importance of post-market surveillance and risk management in ensuring patient safety.In terms of mergers and acquisitions, Eli Lilly's strategic acquisition of Centessa Pharmaceuticals for $6.3 billion signifies its entry into the sleep disorder market. Biogen followed suit by acquiring Apellis Pharmaceuticals for $5.6 billion to strengthen its kidney disease expertise. These moves reflect a broader trend where pharmaceutical giants are diversifying portfolios through acquisitions targeting niche therapeutic areas.On the technological front, partnerships leveraging artificial intelligence (AI) are gaining traction. Bristol Myers Squibb's collaboration with Faro Technologies aims to refine clinical trials using AI, while Merck & Co.'s partnership with Infinimmune focuses on antibody discovery innovations.Financially, Blackstone's record-breaking $6.3 billion life sciences fund highlights robust invSupport the show

Send us a MessageIn this episode of Culture Change RX, Sue Tetzlaff, cofounder of Capstone Leadership Solutions, engages in conversation with Chris Benson from Juniper Advisory about the complexities of healthcare partnerships, particularly in the context of mergers and acquisitions. They discuss the cultural implications of these partnerships, the current trends in hospital consolidations, and navigating the decision-making processes. Healthcare partnerships can take many forms.The decision to partner should be driven by community needs and organizational goals.Many hospitals are still independent, but consolidation is a growing trend.Understanding the motivations behind mergers can help boards make informed decisions.The process of exploring partnerships can take several months and requires careful planning.Engaging stakeholders early in the process is crucial for success.Maintaining a focus on quality care is essential for any partnership. If you would like to connect with Chris or learn more about Juniper Advisory, you can find them here:

So, you're thinking about entering the M&A arena as a buyer? Join Kenny Haglund and Beau Hurtig from Ballard Spahr, LLP, as they walk through a practical checklist of considerations every prospective community bank buyer should evaluate to ensure a smooth acquisition process.Send a textPresented by Remedy ConsultingFor more information on BankTalk:BankTalk WebsiteSubscribe to BankTalk NewsRemedy Consulting WebsiteRemedy LinkedInTo speak on the BankTalk Podcast, please email us.

Frank and Jon unpack: • Why today's competitive landscape means growth-motivated buyers must approach deals differently. • The three core reasons advisors pursue acquisitions - and which ones actually lead to long-term success. • How leverage, bank financing, and EBITDA-based lending really work in practice. • Why “fixer-upper” books may offer the strongest ROI. • How elite buyers win deals by understanding the emotional side of selling a practice. • The art of creating a safe landing place for sellers, their teams, and their clients. • Why phased buyouts and seller glide paths often create better retention and better economics for everyone. Jon also shares numbers, structures, and stories that demystify the math behind buying a practice - and the mindset required to scale from practitioner to true enterprise builder. If you're a buyer, seller, or advisor considering M&A in any form, this episode is a blueprint you can't afford to miss. Resources: Jon Kuttin's LinkedIn: www.linkedin.com/in/jonathankuttin   Elite Consulting Partners | Financial Advisor Transitions: https://eliteconsultingpartners.com Elite Marketing Concepts | Marketing Services for Financial Advisors: https://elitemarketingconcepts.com Elite Advisor Successions | Advisor Mergers and Acquisitions: https://eliteadvisorsuccessions.com JEDI Database Solutions | Data Intelligence for Advisors: https://jedidatabasesolutions.com Listen to more Advisor Talk episodes: https://eliteconsultingpartners.com/podcasts/ Follow us on LinkedIn: https://linkedin.com/company/eliteconsultingpartners Chapters:   00:00 Introduction 01:08 Meet Jon Kuttin 04:42 What Makes a Buyer Truly Ready 13:56 Building Enterprise Value Through Acquisitions 17:20 Managing Risk, Liquidity & Debt Capacity 21:08 Where the Best Acquisition Opportunities Are 35:20 Why Seller Fit Matters More Than Price 42:02 Structuring Glide Paths, Partial Sales & Long-Term Transitions

#104:Welcome back to the Lenders Playbook Podcast. This is episode 104, and I'm your host, Matt Rosen.Today we sit down with Roy Landers. An attorney and former judge... and I've got to say — this was one of the most eye-opening and fun conversations I've had in a while.Roy buys profitable small businesses from retiring owners and scales them with investors. It's an incredible model for entrepreneurs who want to own a business without starting from scratch.Many of these acquisitions also include real estate, creating opportunities for loans backed by strong collateral, cash flow for investors, and sometimes even equity participation when the deal makes sense.We talk about mergers and acquisitions... buying boring, service-based businesses, scaling them, buying more, and eventually exiting.This is truly a fascinating niche, and I know you're going to love this one.First a Quick shoutout to one of the lenders we work with — Deephaven Mortgage.If you're a real estate investor who's ever been told ‘you don't qualify' by a traditional bank, this is exactly why Deephaven exists. They specialize in Non-QM loans, which basically means they look at deals differently — using common sense and flexible underwriting instead of rigid government guidelines.They work with over 1,000 mortgage brokers nationwide and fund loans for investors, landlords, and entrepreneurs who don't always fit the traditional box.Deephaven is headquartered in Charlotte and backed by Pretium, a major investment manager in real estate and mortgage finance.If you're looking for financing on your next deal, reach out to me and I'll see if Deephaven could be a fit. Oct. 9-10, 2026American Lending ConferenceNational Private Lending Conferencehttps://www.americanlendingconference.com/

Key takeaways The LOI is not the final deal. It is more like a handshake on price and core terms, while definitive agreements create the legally binding structure of the transaction. The focus shifts from headline economics to risk allocation, including representations, warranties, indemnification, escrows, working capital, and earnouts. Sellers should expect multiple transaction documents, including the purchase agreement, employment or transition agreements, non-compete and non-solicit provisions, disclosure schedules, and sometimes escrow or lender-related documents. An M&A advisor should protect deal momentum and economics, while legal counsel should focus on legal exposure. Letting attorneys drive business negotiations can create delays and unwanted tradeoffs. Disclosure schedules require a major lift because they support the reps and warranties in the agreement and must fully disclose contracts, employee matters, vendor agreements, litigation issues, notices of termination, and other material business details. Closing day is often surprisingly anticlimactic when the deal has been well managed. Most signatures are already in place, wires are released, and the team confirms final execution and funding. Listen to Shoot the Moon on Apple Podcasts or Spotify.Buy, sell, or grow your tech-enabled services firm with Revenue Rocket.

What really happens after private equity buys your CPA firm? ParkerGale partner Devin Mathews joins Blake to unpack why partners cheer while staff chafe, how PE drives returns (bill rates, utilization, acquisitions), and what managers should demand: a clear value‑creation plan and a path to upside. They also dig into AI's true impact—raising the ceiling, squeezing entry‑level work—and why this might be your cue to start an AI‑first firm.Chapters(00:00) - Private Equity Meets AI (02:04) - Survey Shock Partners vs Staff (04:18) - How PE Boosts Profits (06:17) - Culture Clash and KPIs (09:29) - The New Owner Speech (23:15) - Lessons From Vets and Dentists (25:50) - Pricing Power and Workload (26:39) - How Firms Decide to Sell (27:12) - Deal Tensions Surface (27:25) - LOI And Data Deep Dive (28:20) - Pricing Pressure And Client Cuts (29:48) - Spreadsheet Management Shock (33:20) - Career Paths And Trust (35:02) - Demand The Value Plan (37:13) - Three Problems To Fix (40:00) - AI Threat Or Tailwind (41:35) - AI Reality Check (45:17) - Entry Level Gets Harder (48:47) - Start An AI First Firm (50:56) - Podcast And Farewell Sign up to get free CPE for listening to this podcasthttps://earmarkcpe.comhttps://earmark.app/Download the Earmark CPE App Apple: https://apps.apple.com/us/app/earmark-cpe/id1562599728Android: https://play.google.com/store/apps/details?id=com.earmarkcpe.appConnect with Our Guest, Devin MathewsLinkedIn: https://www.linkedin.com/in/devinmathewsLearn more about ParkerGalehttps://www.parkergale.com/Connect with Blake Oliver, CPALinkedIn: https://www.linkedin.com/in/blaketoliverTwitter: https://twitter.com/blaketoliver/

What's the hidden reality behind entrepreneurship when your company faces a merger or acquisition? Beyond the headlines and the excitement of a potential exit, there's a deeply human side to these transitions—one filled with change, uncertainty, and the need for strong leadership and cultural awareness.In this episode, Marcia Dawood sits down with Jennifer Fondrevay, a former corporate executive turned M&A expert. Having lived through three multi-billion-dollar deals and authored a book on the subject, Jennifer Fondrevay brings a rare perspective focused not just on the transaction, but on the “people piece” that determines true transformation and sustainable success.Together, they explore the most common pitfalls and opportunities in M&A, from the grief staff can experience to the critical role of humility, communication, and early cultural integration. Packed with actionable advice for leaders, founders, and angel investors, this conversation is a must-listen for anyone preparing for, or curious about, what really makes an M&A deal work. To get the latest from Jennifer Fondrevay, you can follow her below!https://www.linkedin.com/in/jennifer-fondrevay/https://jenniferjfondrevay.com/ Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing!Website: www.marciadawood.comDo Good While Doing WellLearn more about the documentary Show Her the Money: www.showherthemoneymovie.comAnd don't forget to follow us wherever you are!Apple Podcasts: https://pod.link/1586445642.appleSpotify: https://pod.link/1586445642.spotifyLinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/Instagram: https://www.instagram.com/theangelnextdoorpodcast/Pinterest: https://www.pinterest.com/theangelnextdoorpodcast/TikTok: https://www.tiktok.com/@marciadawood

EPISODE 245.  Key Takeaways: What due diligence is: The buyer's inspection/audit of the seller's business to confirm the story, financials, contracts, and assumptions made pre-LOI. The emotional shift for sellers: Post-LOI can feel like “we're done,” but diligence is often the most challenging phase and can be exhausting and distracting. Why buyers do it: Risk mitigation and validation, plus identifying upside (synergies, growth investment opportunities, consolidation savings). Common seller mistake: Underestimating diligence and showing up unprepared, both emotionally and operationally. Role of an M&A advisor: First point of contact, ensuring data is clean/defensible, fast response cadence, and pushing back where appropriate. “Scope creep” reality: Multiple outside parties (QoE, tax, legal, integration) often ask overlapping questions, creating a “Groundhog Day” effect without strong process management. Top diligence areas buyers focus on: Revenue quality, customer concentration, contracts/renewals, security posture, key person risk, and scalable delivery model. Retrade risk signals: Business performance softening during diligence, messy financials, messy contracts, or major unexpected changes in the business. Keep momentum (they cite ~90 days as a good diligence window) and don't let diligence distract leadership so much that performance slips. Listen to Shoot the Moon on Apple Podcasts or Spotify.Buy, sell, or grow your tech-enabled services firm with Revenue Rocket.

Welcome to The Exited Founder Podcast, a production of Exitwise!This show is built on one simple idea: founders helping founders. Every episode features a successful Exited Founder who has been through the highs, the lows, and the life-changing moment of selling their business, and is now paying it forward by sharing everything they learned along the way.You'll hear first-hand exit stories from founders across dozens of industries, what they wish they did differently during the M&A process, their takes on current trends, and how they're using their experience to help the next generation of business owners navigate their exit strategy and maximize the value of their company.Every guest is an Exited Founder who now works as an M&A advisor with Exitwise, bringing deep industry expertise and real networks to help founders like you get the exit you deserve. Whether you're thinking about selling your business, preparing for an acquisition, or just starting to explore what an exit could look like, this podcast is for you.Meet our incredible experts and explore the Exited Founder Marketplace at exitwise.com/exited-foundersListen wherever you get your podcasts.

In this episode from WSJ Invest Live, Andy Serwer speaks with Katherine Boyle, general partner at a16z, about the American Dynamism practice she helped launch four years ago. They discuss why saying "America" out loud stunned Silicon Valley in 2022, how Russia's invasion of Ukraine changed everything, and what it means to invest in companies that support the national interest.   Stay Updated:Find a16z on YouTube: YouTubeFind a16z on XFind a16z on LinkedInListen to the a16z Show on SpotifyListen to the a16z Show on Apple PodcastsFollow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The episode centers on structural changes in the Managed Service Provider (MSP) mergers and acquisitions (M&A) landscape, with a focus on the increased influence of private equity (PE), platform strategies, and disciplined deal execution. Dave Sobel and Abraham Garver highlight that the primary driver for buyers has shifted from merely acquiring revenue to seeking operating models that support scale, standardization, and automation. Size of institutional funds directly shapes acquisition targets: funds with $500 million or more increasingly pursue MSPs with minimum EBITDA thresholds, commonly $3–5 million, with larger funds only able to transact at the $10–15 million EBITDA level or above. This signals a market separation, where smaller MSPs face heightened risk of being excluded from future platform opportunities.Supporting these structural shifts, Abraham Garver explains that the buyers' value assessment increasingly prioritizes new customer acquisition over one-off gains from cross-sales like cybersecurity add-ons. Organic growth, shown through the consistent addition of new client logos, outweighs temporary revenue boosts in determining valuation. The episode also outlines that AI investment and automation stories are not materially lifting valuations for smaller MSPs, unless directly reflected in improved financials. Larger providers may have the resources to invest meaningfully in AI, but for the majority—especially those below $10 million in revenue—outsourcing or leveraging third-party solutions is more practical than bespoke, high-cost internal development.A further operational risk discussed is the prevalence of "retrading"—buyers renegotiating valuations post–Letter of Intent (LOI) based on due diligence findings. Abraham Garver reveals that 60% of transactions see price reductions after the LOI, often for factors such as recent customer losses or missed forecasts, diverging from initial headline multiples. This reality highlights the importance of diligent contract negotiation, clear documentation, and the value of experienced advisors to navigate buyer tactics. Rob Calvert contributes additional insight on workflow and technology alignment, emphasizing the role of standardized onboarding and offboarding processes in reducing both operational friction and security gaps.For MSPs and IT service providers, the discussion clarifies several critical implications. First, with platform buyers seeking scale, only MSPs meeting explicit EBITDA and growth metrics will attract competitive offers; others should realistically assess the cost and likelihood of reinvention versus sale. Second, buyers' focus on execution and organic growth, not headline multiples or claims of technological advancement, makes robust financial performance and client acquisition strategies essential to preserving value. Third, the commonality of post-LOI repricing underlines the need for rigorous pre-sale diligence, explicit contractual terms, and experienced representation to preserve deal value and protect against downside risk. Lastly, operational standardization—especially in device and data management—remains central to both platform attractiveness and risk mitigation.

AI is changing how companies are built and how venture firms operate, forcing faster decisions, clearer judgment, and new ways of working.In this exclusive conversation, Ben Horowitz shares how Andreessen Horowitz adapts to that shift. He explains why managing GPs is different from running a company, how investors are evaluated at the moment of decision rather than years later, and why verticalized teams help the firm scale without internal politics.Ben also breaks down the current AI cycle, from treating AI as a new computing platform to why application design and model orchestration matter more than raw model size. He discusses the return of M&A and why today's AI market reflects real demand, not just inflated valuations. Resources:Follow Ben on X: https://twitter.com/bhorowitzFollow Jen on X: https://twitter.com/jkhamehl  Read Justine's piece ‘There is No God Tier Video Model': https://a16z.com/there-is-no-god-tier-video-model-but-there-is-something-better/ Stay Updated:If you enjoyed this episode, be sure to like, subscribe, and share with your friends!Find a16z on X :https://twitter.com/a16zFind a16z on LinkedIn: https://www.linkedin.com/company/a16zListen to the a16z Podcast on Spotify: https://open.spotify.com/show/5bC65RDvs3oxnLyqqvkUYXListen to the a16z Podcast on Apple Podcasts: https://podcasts.apple.com/us/podcast/a16z-podcast/id842818711Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Stay Updated:Find a16z on XFind a16z on LinkedInListen to the a16z Show on SpotifyListen to the a16z Show on Apple PodcastsFollow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.